legal dispute A subsidiary of Scotts Miracle-Gro pits an investment fund controlled by the CEO of multi-state cannabis operator TerrAscend have been settledwith the MSO-linked investment fund actually agreeing to buy from a deal involving the purchase of the New York medical marijuana company.
RIV Capital, a Toronto-based investment firm It was funded in part by Hawthorne Collective, a cannabis-focused subsidiary of Scotts, announced the settlement in a press release Thursday.
Scotts has funded legalization efforts in the Northeast and is trying to enter the retail cannabis market in this part of the country.
This past March, RIV Capital announced that it had struck a Deal to buy Etain Health For $247 million.
Etain is one of 10 vertically integrated medical marijuana businesses permitted in New York State under current law.
The company has locations in Midtown Manhattan as well as upstate.
Read the full article at Marijuana Business Daily